# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Needham analyst Gil Blum reiterates Geron (NASDAQ:GERN) with a Buy and maintains $5 price target.
Geron (NASDAQ:GERN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 p...
Baird analyst Joel Beatty downgrades Geron (NASDAQ:GERN) from Outperform to Neutral and maintains $4.5 price target.
TD Cowen analyst Tara Bancroft initiates coverage on Geron (NASDAQ:GERN) with a Buy rating and announces Price Target of $10.
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sh...